avanafil - CISMeF

Preferred Label : avanafil;

CISMeF synonym : 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

Is substance : O;

Details

Origin ID

M0551615;

UMLS CUI

C2698280;

Automatic exact mappings (from CISMeF team)
- Product containing avanafil (medicinal product) [SNOMED CT concept]
CISMeF manual mappings
- Avanafil (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Avanafil [SMS substance]
- Avanafil [ICD-11 Extension code]
- Avanafil [NCIt concept]
- avanafil [International Nonproprietary Name]
MeSH narrower concept(s)
- stendra [MeSH concept]
Related record
- avanafil [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Avanafil [NCIt concept]
- Avanafil (substance) [SNOMED CT concept]
- Product containing avanafil (medicinal product) [SNOMED CT concept]
- avanafil [ATC Code]
- avanafil [International Nonproprietary Name]
Validated automatic mappings to BTNT
- avanafil [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients